Skip to main content

Find Clinical Trials

Home
Conditions
Diffuse Large B Cell Lymphoma

Clinical trial condition

Diffuse Large B Cell Lymphoma

Explore clinical trials studying Diffuse Large B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

165 public trials 52 recruiting studies

Refine in advanced search Browse all conditions

Diffuse Large B Cell Lymphoma trial results

Not Yet Recruiting

A Real-World Study on Extranodal Lymphoma

NCT06573099

Conditions: Diffuse Large B Cell Lymphoma, Extranodal Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study Comparing the Efficacy and Safety of Pola-RCHP-X Versus RCHOP-X and Pola-RCHP in Previously Untreated Patients With DLBCL

NCT06516978

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Maintenance Hormonal Therapy and DLBCL

NCT06355401

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

(CHANT)Real World Study of Duvelisib in the Treatment of Non-Hodgkin's Lymphoma (NHL)

NCT05923502

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Diffuse Large B Cell Lymphoma, +27 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Omic Technologies Applied to the Study of B-cell Lymphoma for the Discovery of Diagnostic and Prognosis Biomarkers

NCT05834426

Conditions: Cancer, Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, +13 more
Locations: Instituto Oncológico Nacional Dr. Juan Tanca Marengo Guayaquil, Guayas, Ecuador

View Trial Details

Not Yet Recruiting

Predictive Biomarkers Including miRNA-based Tumor Signatures in Diffuse Large B Cell Lymphoma (R/R DLBCL) (MIMOSA)

NCT05746858

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: Istituto Nazionale Tumori Fondazione "G. Pascale" IRCCS Naples, Italy

Fonadazione Policlinico Universitario A. Gemelli Roma, Italy

Istituti Fisioterapici Ospitalieri -Istituto Regina Elena Roma, Italy

View Trial Details

Not Yet Recruiting

Electronic MonitorIng of Events for dIffuse Large b Cell LYmphoma

NCT05298293

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: Polyclinique Bordeaux Nord Aquitaine Bordeaux, France

Clinique Victor Hugo/Centre Jean Bernard/ILC Le Mans, France

Hôpital Privée du Confluent Nantes, France

Centre Hospitalier de St Nazaire Saint-Nazaire, France

View Trial Details

Completed

Copanlisib in Combination With Rituximab and CHOP Chemotherapy in Patients With Previously Untreated DLBCL

NCT04263584

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations: University Hospital RWTH Aachen Aachen, Germany

Haematology and Oncology Practice Augsburg, Germany

Klinikum-Bremen-Mitte Bremen, Germany

St.-Johannes-Hospital Dortmund Dortmund, Germany

View all 16 locations

View Trial Details

Completed

Thrombosis in Diffuse Large B-cell Lymphoma:the PREDIC-TO (PREDICt ThrOmbosis) Study

NCT06694779

Conditions: Cardiovascular Diseases, Diffuse Large B Cell Lymphoma, Embolism and Thrombosis, +13 more
Locations: Ivan Civettini Monza, Italy

View Trial Details

Completed

Pembrolizumab After ASCT for Hodgkin Lymphoma, DLBCL and T-NHL

NCT02362997

Conditions: Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +14 more
Locations: City of Hope National Medical Center Duarte, California, United States

Massachusetts General Hospital Boston, Massachusetts, United States

Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details